Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACAM-CDIFF in Subjects With Clostridium Difficile Infection
NCT00772343Phase 2Completed
- Sponsor
- Sanofi
- Start
- Feb 2009
- Primary completion
- Jul 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
A Phase 2 trial of ACAM-CDIFF in Clostridioides difficile infection (CDI), sponsored by Sanofi. Started Feb 2009; status: completed.
02
Drugs
ACAM-CDIFF
03
Conditions
Clostridioides difficile infection (CDI)
Beyond the preview
Go deeper on NCT00772343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00772343.